MedPath

Positron Emission Tomography for detection of histologic transformation of indolent non-Hodgkin’s lymphoma: a pilot study

Conditions
on Hodgkin Lymphoma
Positron Emission Tomography
Registration Number
NL-OMON23241
Lead Sponsor
VU Medical Center Amsterdam, department of Hematology.
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
34
Inclusion Criteria

1. Patients with newly diagnosed follicular lymphoma or newly diagnosed histological transformation of follicular lymphoma proven by histological examination.

2. Ann Arbor stage at diagnosis: II, III or IV.

Exclusion Criteria

1. Uncontrolled diabetes mellitus.

2. Physical inability to access PET facilities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- Maximal Standard Uptake Value (SUVmax), SUV mean and intraindividual variability
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath